Profil
Dr. Dimitris Voliotis, MD, is a Chief Medical Officer at Radiopharm Theranostics Ltd. Dr. Voliotis was previously employed as a Senior Vice President-Clinical Development by Zentalis Pharmaceuticals, Inc., a Chief Development Officer by CureVac AG, a Global Head-Clinical Development Oncology by Eisai, Inc., and a Vice President & Head-Oncology Group by Bayer HealthCare AG.
He received his doctorate degree from Universität zu Köln.
Postes actifs de Dimitris Voliotis
| Sociétés | Poste | Début |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Directeur Technique/Scientifique/R&D | 20/08/2024 |
Anciens postes connus de Dimitris Voliotis
| Sociétés | Poste | Fin |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2023 |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Corporate Officer/Principal | 01/02/2020 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01/01/2019 |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Corporate Officer/Principal | 01/09/2014 |
Formation de Dimitris Voliotis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Radiopharm Theranostics Ltd.
Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
















